I think everyone shares these thoughts and certainly hope that’s the case. It would be huge for the Rett girls around the world, and huge for shareholders. We can only hope…. I bet Dr M is dying to relay any new, positive communication with the FDA.
Freudian slip, a moment of confusion or half truth when Missling said suggest/approved by the FDA vs. the 8-K PR stating the endpoint changes and upgrade to P3 was agreed with the UK and AU regulators.
Imo it would prudent of investors and Anavex to go with the 8-K filing as the basis of investor reliance.
Anything else is lies or wishful thinking both of which occasionally works out with impunity.
Btw. if we see early approval for Rett, it will come from the UK imo.
News 
Market Data 
Discover 
AI
